RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity
- Resource Type
- Journal
- Source
MOLECULAR CANCER THERAPEUTICS ; DEC 1 2020, 19 12, p2585-p2597, 13p.- Subject
- Language
- English
- ISSN
- 15388514